Return-to-play decisions in athletes with cardiac conditions

Physician and Sportsmedicine

Volumn 37, Issue 1, 2009, Pages 80-91

  Lawless, Christine E ^a  

^a Sports Cardiology Consultants LLC   (United States)

Author keywords

Athletes with cardiac conditions; Heart disease; Preparticipation screening; Return to play guidelines

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ATHLETE; BRUGADA SYNDROME; CATHETER ABLATION; CLINICAL PRACTICE; CONFERENCE PAPER; CONGENITAL HEART DISEASE; CORONARY ARTERY ANOMALY; DECISION MAKING; DEFIBRILLATOR; ELECTROCARDIOGRAM; EUROPE; EXERCISE; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HEART SURGERY; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MARFAN SYNDROME; MEDICAL SOCIETY; MYOCARDITIS; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; RECREATION; SPORT; SUDDEN DEATH; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; COMPETITIVE BEHAVIOR; CONSENSUS DEVELOPMENT CONFERENCES, NIH AS TOPIC; DEATH, SUDDEN, CARDIAC; DECISION MAKING; DISEASE SUSCEPTIBILITY; ELECTROCARDIOGRAPHY; EUROPE; FORECASTING; GUIDELINES AS TOPIC; HUMANS; MASS SCREENING; RISK ASSESSMENT; RISK FACTORS; SPORTS; SPORTS MEDICINE; TIME FACTORS; UNITED STATES;

EID: 75849124407     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/PSM.2009.04.1686     Document Type: Conference Paper

References (46)

1. Street and Smith's Sports Business Daily. Team sports participation in the US up for organized leagues. Published Sept 10,2008. Available at: http://www.sportsbusinessdaily.com/article/123897. Accessed March 18, 2009.
2. Maron, BJ, Thompson PD, Ackerman M, et al; American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-1655.
3. Maron BJ, Zipes DP. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol. 2005;45(8):1318-1321.
4. Maron BJ, Mitten MJ, Quandt EF, et al. Competitive athletes with cardiovascular disease - the case of Nicholas Knapp. N Engl J Med. 1998;339(22):1632-1635.
5. Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422-1445.
6. Pelliccia A, Corrado D, Bjørnstad HH, et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil. 2006;13(6):876-885.
7. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of US and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52(24):1990-1996.
8. Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008;358(2):152-161.
9. Maron BJ, Chaitman BR, Ackerman MJ, et al; Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807-2816.
10. Estes NA III, Link MS, Cannom D, et al; Expert Consensus Conference on Arrhythmias in the Athlete of the North American Society of Pacing and Electrophysiololgy. Report of the NASPE policy conference on arrhyth-mias and the athlete. J Cadiovasc Electrophysiol. 2001;12(10):1208-1219.
11. Maron BJ, Araujo CG, Thompson PD, et al; World Heart Federation; International Federation ofSports Medicine; American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2001;103(2):327-334.
12. Thompson PD, Franklin BA, Balady GJ, et al; American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Heart Association Council on Clinical Cardiology, American College of Sports Medicine. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation. 2007;115(17):2358-2368.
13. Thompson PD, Funk EJ, Carleton RA, Sturner WQ. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA. 1982;247(18):2535-2538.
14. Lampert R, Cannom D, Olshansky B. Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society members. J Cardiovasc Electrophysiol. 2006;17(1):11-15.
15. Lawless CE. Implantable cardioverter defibrillators in athletes: rationale for use and issues surrounding return to play. Curr Sports Med Rep. 2008;7(2):86-92.
16. Lawless CE, Lampert R, Olshansky B, Cannom D. Safety and efficacy of implantable defibrillators and automatic external defibrillators in athletes: results of a nationwide survey among AMSSM members. Clinical Journal of Sport Medicine. 2005;15(5)-386-391.
17. Yale coordinating center, ICD Sports Registry, http://www.ncaa.org/wps/ wcm/connect/re sources/file/ebe950479495c57/ICD%20sports%20registry%20brochure. pdf?MOD=AJPERES. Accessed April 15, 2009.
18. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of betablocker therapy in congenital long-QT syndrome. Circulation. 2000;101(6):16-623.
19. Priori SG, Napolitano C, Schwartz PJ, et al. Association of long QT syndrome loci and cardiac events among patients treated with betablockers. JAMA. 2004;292(11):1341-1344.
20. Vanhees L, Defoor JG, Schepers D, et al. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men. J Hypertens. 2000;18(1):35-43.
21. Savage DD, Seides Sf, Clark CE, et al. Electrocardiographic findings in patients with obstructive and non-obstructive hypertrophic cardiomy-opathy. Circulation. 1978;58(3 Pt 1):402-408.
22. Thompson PD, Franklin BA, Balady GJ, et al; American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Heart Association Council on Clinical Cardiology, American College of Sports Medicine. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation. 2007;115(17):2358-2368.
23. Thompson PD, Buchner D, Pina IL, et al; American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Rehabilitation, and Prevention; American Heart Association Council on Nutrition, Physical Activity, and Metabolism Subcommittee on Physical Activity. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107(24):3109-3116.
24. Passino C, Severino S, Poletti R, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol. 2006;47(9):1835-1839.
25. Piña IL, Apstein CS, Balady GJ, et al; American Heart Association Committee on exercise, rehabilitation, and prevention. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention Circulation. 2003;107(8):1210-1225.
26. Whellan DJ, O'Conner CM, Lee KL, et al. HF-ACTION Trial Investigators. Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J. 2007;153(2):201-211.
27. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349(11):1064-1075.
28. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990;89(5):588-596.
29. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318(3):129-133.
30. Heidbüchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J. 2003;24(16):1473-1480.
31. Angelini P, Velasco JA, Flamm S. Coronary anomalies: incidence, pathophysiology, and clinical relevance. Circulation. 2002;105(20):2449-2454.
32. Calkins H, Yong R Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999;99(2):262-270.
33. Naccarelli GV, Shih H, Jalal S. Catheter ablation for the treatment of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol. 1995;6(10 pt 2):951-961.
34. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 1979;301(20):1080-1085.
35. Pappone C, Santinelli V, Rosanio S, et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in symptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol. 2003;41(2):239-244.
36. Pappone C, Santinelli V, Manguso F, et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med. 2003;349(19):1803-1811.
37. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40(3):446-452.
38. Biffi A, Maron BJ, Verdile L, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2004;44(5):1053-1058.
39. Cole CR, Marrouche NF, Natale A. Evaluation and management of ventricular outflow tract tachycardias. Card Electrophysiol Rev. 2002;6(4):442-447.
40. Lerman BB, Stein KM, Markowitz SM, Mittal S, Slotwiner DJ. Ventricular arrhythmias in normal hearts. Cardiol Clin. 2000;18(2):265-291.
41. Maruyama M, Tadera T, Miyamoto S, Ino T. Demonstration of the reentrant circuit of verapamil-sensitive idiopathic left ventricular tachycardia: direct evidence for macroreentry as the underlying mechanism. J Cardiovasc Electrophysiol. 2001;12(S):968-972.
42. Nogaini A. Idiopathic left ventricular tachycardia: assessment and treatment. Card Electrophysiol Rev. 2002;6(4):448-457.
43. Ouyang F, Cappato R, Ernst S, et al. Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network. Circulation. 2002;105(4):462-469.
44. Lawless CE, Best TM. Electrocardiograms in athletes: interpretation and diagnostic accuracy. Med Sci Sports Exerc. 2008;40(5):787-798.
45. Spataro A, Pelliccia A, Rizzo, M, Biffi A, Masazza G, Pigozzi F. The natural course of bicuspid aortic valve in athletes. Int J Sports Med. 2008;29(1):81-85.
46. Jacobs W, Chamoun, A, Stoutter GA. Mitral valve prolapse: a review of the literature. Am J Med Sci. 2001;321(6):401-410.